ARFGAP3
ADP-ribosylation factor GTPase-activating protein 3
Also known as: ARFG3_HUMAN, ARFGAP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NP61
- Gene
- ARFGAP3
- Ensembl
- ENSG00000242247
- Chromosome
- 22
- Canonical length
- 516 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a GTPase-activating protein (GAP) that associates with the Golgi apparatus and regulates the early secretory pathway of proteins. The encoded protein promotes hydrolysis of ADP-ribosylation factor 1 (ARF1)-bound GTP, which is required for the dissociation of coat proteins from Golgi-derived membranes and vesicles. Dissociation of the coat proteins is a prerequisite for the fusion of these vesicles with target compartments. The activity of this protein is sensitive to phospholipids. Multiple transcript variants encoding different isoforms have been found for this gene. This gene was originally known as ARFGAP1, but that is now the name of a related but different gene. [provided by RefSeq, Nov 2008]
Canonical amino-acid sequenceUniProt
516 residues, UniProt reviewed canonical sequence.
>Q9NP61|ARFGAP3
1 MGDPSKQDIL TIFKRLRSVP TNKVCFDCGA KNPSWASITY GVFLCIDCSG SHRSLGVHLS
61 FIRSTELDSN WSWFQLRCMQ VGGNASASSF FHQHGCSTND TNAKYNSRAA QLYREKIKSL
121 ASQATRKHGT DLWLDSCVVP PLSPPPKEED FFASHVSPEV SDTAWASAIA EPSSLTSRPV
181 ETTLENNEGG QEQGPSVEGL NVPTKATLEV SSIIKKKPNQ AKKGLGAKKG SLGAQKLANT
241 CFNEIEKQAQ AADKMKEQED LAKVVSKEES IVSSLRLAYK DLEIQMKKDE KMNISGKKNV
301 DSDRLGMGFG NCRSVISHSV TSDMQTIEQE SPIMAKPRKK YNDDSDDSYF TSSSSYFDEP
361 VELRSSSFSS WDDSSDSYWK KETSKDTETV LKTTGYSDRP TARRKPDYEP VENTDEAQKK
421 FGNVKAISSD MYFGRQSQAD YETRARLERL SASSSISSAD LFEEPRKQPA GNYSLSSVLP
481 NAPDMAQFKQ GVRSVAGKLS VFANGVVTSI QDRYGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARFGAP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 85 nTPM
- adrenal gland: 84 nTPM
- salivary gland: 65 nTPM
- prostate: 61 nTPM
- thyroid gland: 57 nTPM
- cervix: 53 nTPM
Single-cell type
- pancreatic acinar cells: 327 nCPM
- neutrophils: 316 nCPM
- prostatic glandular cells: 294 nCPM
- endometrial glandular cells: 252 nCPM
- salivary acinar cells: 249 nCPM
- plasma cells: 245 nCPM
Immune cell
- basophil: 87 nTPM
- MAIT T-cell: 59 nTPM
- plasmacytoid DC: 53 nTPM
- non-classical monocyte: 51 nTPM
- neutrophil: 51 nTPM
- NK-cell: 50 nTPM
Brain region
- choroid plexus: 37 nTPM
- medulla oblongata: 32 nTPM
- hypothalamus: 32 nTPM
- white matter: 31 nTPM
- thalamus: 29 nTPM
- spinal cord: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.47
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- COPI coating of Golgi vesicle
- intracellular protein transport
- protein secretion
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARFGAP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARFGAP3 as an antibody target. Whether an autoantibody or antibody against ARFGAP3 could matter depends on whether native ARFGAP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARFGAP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARFGAP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...